The effect of the antithyroid drug propylthiouracil on the alternative pathway of complement in rats

International Journal of Immunopharmacology

Volumn 22, Issue 1, 2000, Pages 25-33

  Duarte, Celma Gonçalves ^a   Dos Santos, Georgina L ^a   Azzolini, Ana Elisa Caleiro Seixas ^a   De Assis Pandochi, Ana Isabel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alternative pathway; Complement; Propylthiouracil; Thionamide

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; CELL RECEPTOR; PROPYLTHIOURACIL; THIONAMIDE; THYRONINE; THYROXINE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; CYTOLYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE RESPONSE; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; THYROID HORMONE BLOOD LEVEL;

ANIMALS; ANTITHYROID AGENTS; COMPLEMENT PATHWAY, ALTERNATIVE; MALE; PROPYLTHIOURACIL; RATS; RATS, WISTAR; THYROID HORMONES;

EID: 0033964183     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00061-2     Document Type: Article

References (50)

1. Assis A.I., Barbosa J.E., de Carvalho I.F. Anticomplementary fraction from the poisonous secretion of the paratoid gland of the toad (Bufo marinus paracnemis Luz). Experientia. 41:1985;940-942.
2. Bitter-Suermann D., Hadding U., Schorlemmer H.U., Limbert M., Dierich M., Dukor P. Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement system. J. Immunol. 115:1975;425-430.
3. Cooper D.S., Kieffer J.D., Halpern R., Saxe V., Mover H., Maloof F., Ridgway E.C. Propylthiouracil (PTU) pharmacology in the rat. II effects of PTU on thyroid function. Endocrinol. 113:(3):1983;921-928.
4. Cope O., Kapnick I. The relation of endocrine function to resistance and immunity. Endocrinol. 2:1940;533-542.
5. Eisenstein Z., Engelsman E., Weiss M., Kalechman Y., Sredni B. Modulation of the IL-2 production defect in vitro in Graves' disease. Clin. Exp. Immunol. 96:(2):1994;323-328.
6. Embling P.H., Evans H., Guttierez C., Holborow E.J., Johns P., Johnson P.M., Papamichail M., Stanworth D.R. The structural requirements for immunoglobulin aggregates to localize in germinal centres. Immunology. 34:1978;781-786.
7. Erdei A., Füst G., Gergely J. The role of C3 in the immune response. Immunol. Today. 12:1991;332-337.
8. Ewald R.A., Williams J.H., Bowden D.H. Serum complement in the newborn. An investigation of complement activity in normal infants and in Rh and AB hemolytic disease. Vox. Sang. 6:1961;312-319.
9. Fearon D.T. The complement system and adaptative immunity. Semin. Immunol. 10:(5):1998;335-361.
10. Feldbush T.L., Hobbs M.V., Severson C.D., Ballas Z.K., Weiler J.M. Role of complement in the immune response. Fed. Proc. 43:1984;2548-2552.
11. Ferriani V.P.L., Barbosa J.E., Carvalho I.F. Serum haemolytic classical and alternative pathways of complement in infancy: age-related changes. Acta Paediatr. Scand. 79:1990;322-327.
12. Ferreira D.A., Santos G.L., Azzolini A.E.C.S., Assis-Pandochi A.I. Complement levels in hypothyroid and hyperthyroid rats. Exp. Clin. Immunogenet. 14:1997;32.
13. Franklyn J.A. The management of hyperthyroidism. N. Engl. J. Med. 330:(4):1994;1731-1738.
14. Gordon P., Benditt E.P. Influence of hormones (growth, ACTH, thyrotrophic and cortisone) upon complement level in rabbits. Proc. Soc. Exp. Biol. 89:1955;286-288.
15. Harrison R.A., Lachmann P.J. Complement technology. Weir D.M. Handbook of experimental immunology, Chapter 39, 4th ed. vol. 1:1986;39.1-49 Blackwell Scientific Publications.
16. Hofmamm L.G., Mayer M.M. Immune hemolysis and complement fixation. Williams C.A., Chase M.W. Methods in immunology and immunochemistry. 1977;140 Academic Press, New York.
17. Kai O., Nagase H., Ishikawa N., Suzuki M., Kakegawa T., Sato K. Effects of propylthiouracil (PTU) on the immunological status of the chicken. Develop. Comp. Immunol. 12:1988;145-156.
18. Kai O., Nagase H., Ishikawa N., Suzuki M., Kakegawa T., Sato K. Effects of hypothyroidism with treatment with an anti-thyroid drug, propylthiouracil on immune responses in chicken. Vet. Immunol. Immunopathol. 36:1993;123-135.
19. Kendall-Taylor P. Are antithyroid drugs immunosuppressive? Brit. Med. J. 288:1984;509-511.
20. Kinoshita T. Biology of complement: the overture. Immunol. Today. 12:(9):1991;291-295.
21. Larsen P.R., Ingbar S.H. The thyroid gland. Wilson, Foster D.W. Willians textbook of endocrinology. 8th ed. 1992;682-815 WB Saunders Company.
22. Laurell C.B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal. Biochem. 15:1966;45-52.
23. Luxembourg A.T., Cooper N.R. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J. Immunol. 153:1994;4448-4457.
24. Marazuela M., Vargas J.A., Alvarez-Mon M., Albarran F., Lucas T., Durantez A. Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease. Eur. J. Endocrinol. 132:(2):1995;175-180.
25. McGregor A.M., Petersen M.M., McLachlan S.M., Rooke P., Smith B.R., Hall R. Carbimazole and the autoimmune response in Graves disease. New Engl. J. Med. 303:1980;302-307.
26. Ochs H.D., Nonoyama S., Zhu Q., Farrington M., Wedgwood R.J. Regulation of antibody response: the role of complement and adhesion molecules. Clin. Immunol. Immunopath. 67:1993;S33-S40.
27. Ochs H.D., Wedgwood R.J., Frank M.M., Heller S.R., Hosea S.W. The role of complement in the induction of antibody responses. Clin. Exp. Immunol. 53:1983;208-216.
28. Pacini F., Nakamura H., DeGroot L.J. Effect of hypo and hyperthyroidism on the balance between helper and suppressor T cells in rats. Acta. Endocrinol. 103:1983;528-534.
29. Pepys M.B. Role of complement in induction of antibody production in vivo. Effect of cobra venom factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. Exp. Med. 140:1974;126-145.
30. Polhill R.B., Pruitt K.M., Johnston R.B. Jr. Kinetic assessment of alternative complement pathway activity in a hemolytic system. I. Experimental and mathematical analysis. J. Immunol. 121:(1):1978;363-370.
31. Qin D., Wu J., Carroll M.C., Burton G.F., Szakal A.K., Tew J.G. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. J. Immunol. 161:(9):1998;4549-4554.
32. Romaldini J.H., Bromberg N., Werner R.S., Tanaka L.M., Rodrigues H.F., Werner M.C., Farah C.S., Reis L.C.F. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' Hyperthyroidism. J. Clin. Endocrinol. Metab. 57:1983;563-570.
33. Rennie D.P., McGregor A.M., Keast D., Weetman A.P., Foord S.M., Diegues C., Williamns E.D., Hall R. The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinol. 112:1983;326-330.
34. Ross G., Medof M.E. Membrane complement receptors specific for bound fragments of C3. Adv. Immunol. 37:1985;217-267.
35. Rosseel M.T., Lefebvre. High-performance liquid chromatographic determination of propylthiouracil in plasma. J. Chromat. 507:1990;247-251.
36. Russo E.M.S., Assis-Pandochi A.I., Lucisano-Valim Y.M. Effect of propylthiouracil on serum opsonizing activity and on neutrophil phagocytosis. Exp. Clin. Immunogenet. 14:1997;36.
37. Russo E.M.S., Azzolini A.E.C.S., Assis-Pandochi A.I., Lucisano-Valim Y.M. A study of the opsonizing activity of serum complement from rats treated with propylthiouracil, dependently of the alternative pathway. Molec. Immunol. 35:1998;314.
38. Sharma B.S., Elias A.N. Effects of methimazole on human lymphocyte proliferation and natural killer cell activity. Gen. Pharmacol. 18:(4):1987;449-453.
39. Tolnay M., Tsokos G.C. Complement receptor 2 in the regulation of the immune response. Clin. Immunol. Immunopathol. 88:(2):1998;123-132.
40. Villiers C.L., Villiers M.B., Marche P.N. Role of the complement C3 protein in the control of the specific immune response. Ann. Biol. Clin. 157:(2):1999;27-135.
41. Volpé R. Evidence that the immunosuppressive effects of antithyroid drugs are mediated through actions on the thyroid cell, modulating thyrocyte-immunocyte signaling. Thyroid. 4:1994;217-223.
42. 3H-thymidine incorporation into DNA of peripheral blood lymphocytes after the addition of propylthiouracil. J. Clin. Endocrinol. Metab. 43:1976;1406-1409.
43. Weetman A.P. The immunomodulatory effects of antithyroid drugs. Thyroid. 4:(2):1994;145-146.
44. Weetman A.P., McGregor A.M. Autoimmune thyroid disease: further developments in our understanding. Endocrine Rev. 15:(6):1994;788-830.
45. Weetman A.P., Holt M.E., Campbell A.K., Hall R., McGregor A.M. Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression. Brit. Med. J. 288:1984;518-520.
46. Weetman A.P., McGregor A.M., Hall R. Methimazole inhibits thyroid autoantibody production by an action on accessory cells. Clin. Immunol. Immunopath. 28:1983;39-45.
47. Weigle W.O., Goodman M.G., Morgan E.L., Hugli T.E. Regulation of immune response by components of the complement cascade and their activated fragments. Springer Semin. Immunopathol. 6:1983;173-194.
48. Wenzel K.W., Lente J.R. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs. J. Clin. Endocrinol. Metab. 58:1984;62-69.
49. Wilson R., McKillops J.H., Choppra M., Thomson J.A. The effect of antithyroid drugs on B and T cell activity in vitro. Clin. Endocrinol. 28:1988;389-397.
50. Wilson R., McKillop J.H., Travers M., Smith J., Smith E., Thomson J.A. The effects of antithyroid drugs on intercellular mediadores. Act. Endocrinol. 122:1990;605-609.